The answer for treating a condition that causes potentially life-threatening blood clots may be found in the form of genetically modified goats. If the FDA approves it, of course. ATryn, a drug developed by a Massachusetts biotechnology company, GTC Biotherapeutics, is made from goats’ milk specially formulated to contain antithrombin. In humans, antithrombin acts as a blood thinner. However, about one in 5,000 people do not produce enough of this hormone,... Read More »






Most Commented